ACS Medicinal Chemistry Letters
Page 6 of 7
sponse to nucleoside drugs. Nucleosides Nucleotides Nucleic
transporter from human kidney: cloning and functional charac-
1
2
3
4
5
6
7
8
Acids 2009, 28, 450-463.
terization. Am. J. Physiol. 1997, 273, F1058-F1065.
(13) Okayama, T.; Yoshisue, K.; Kuwata, K.; Komuro, M.; Ohta,
S.; Nagayama, S. Involvement of concentrative nucleoside trans-
porter 1 in intestinal absorption of trifluorothymidine, a novel
antitumor nucleoside, in rats. J. Pharmacol. Exp. Ther. 2012, 340,
457-462.
(14) Molina-Arcas, M.; Casado, F. J.; Pastor-Anglada, M. Nucleo-
side transporter proteins. Curr. Vasc. Pharmacol. 2009, 7, 426-
434.
(15) Parkinson, F. E.; Damaraju, V. L.; Graham, K.; Yao, S. Y.M.;
Baldwin, S. A.; Cass, C. E.; Yound, J. D. Molecular biology of nu-
cleoside transporters and their distributions and functions in the
brain. Curr. Top. Med. Chem. 2011, 11, 948-972.
(24) Ritzel, M. W.; Ng, A. M.; Yao, S. Y.; Graham, K.; Loewen, S.
K.; Smith, K. M.; Ritzel, R. G.; Mowles, D. A.; Carpenter, P.; Chen,
X.-Z.; Karpinski, E.; Hyde, R. J.; Baldwin, S. A.; Cass, C. E.; Yound,
J. D. Molecular identification and characterization of novel hu-
man and mouse concentrative Na+-cotransporter proteins
(hCNT3 and mCNT3) broadly selective for purine and pyrimi-
dine nucleosides (system cib). J. Biol. Chem. 2001, 276, 2914-2927.
(25) Hiratochi, M.; Tatani, K.; Shimizu, K.; Kuramochi, Y.; Kiku-
chi, N.; Kamada, N.; Itoh, F.; Isaji, M. Hypouricemic effects of
novel concentrative nucleoside transporter 2 inhibitors through
suppressing intestinal absorption of purine nucleosides. Eur. J.
Pharmacol. 2012, 690, 183-191.
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
(16) Gray, J. H.; Owen, R. P.; Giacomini, K. M. The concentrative
nucleoside transporter family, SLC28. Pflugers Arch. 2004, 447,
728-734.
(17) Baldwin, S. A.; Beal, P. R.; Yao, S. Y.M.; King, A. E.; Cass, C.
E.; Yound, J. D. The equilibrative nucleoside transporter family,
SLC29. Pflugers Arch. 2004, 447, 735-743.
(18) Kong, W.; Engel, K.; Wang, J. Mammalian nucleoside trans-
porters. Curr. Drug Metab. 2004, 5, 63-84.
(19) Lai, Y.; Bakken, A. H; Unadkat, J. D. Simultaneous expres-
sion of hCNT1-CFP and hENT1-YEP in Madin-Darby canine kid-
ney cells. J. Biol. Chem. 2002, 277, 37711-37717.
(26) Shin, H.-C.; Landowski, C. P.; Sun, D.; Vig, B. S.; Kim, I.;
Mittal, S.; Lane, M.; Rosania, G.; Drach, J. C.; Amidon, G. L.
Functional expression and characterization of
a sodium-
dependent nucleoside transporter hCNT2 cloned from human
duodenum. Biochem. Biophys. Res. Commun. 2003, 307, 696-703.
(27) Gupte, A.; Buolamwini, J. K. Synthesis and biological evalu-
ation of phlorizin analogs as human concentrative nucleoside
transporter 3 (hCNT3) inhibitors. Bioorg. Med. Chem. Lett. 2009,
19, 917-921.
(28) Wang, C.; Pimple, S.; Buolamwini, J. K. Interaction of ben-
zopyranone derivatives and related compounds with human
concentrative nucleoside transporters 1, 2 and 3 heterologously
expressed in porcine PK15 nucleoside transporter deficient cells.
Structure-activity relationships and determinants of transporter
affinity and selectivity. Biochem. Pharmacol. 2010, 79, 307-320.
(29) Cnang, C.; Swaan, P. W.; Ngo, L. Y.; Lum, P. Y.; Patil, S. D.;
Unadkat, J. D. Molecular requirements of the human nucleoside
transporters hCNT1, hCNT2, and hENT1. Mol. Pharmacol. 2004,
65, 558-570.
(20) Huang, Q.-Q.; Yao, S. M.; Ritzel, M. W.; Paterson, A. R.;
Cass, C. E.; Yound, J. D. Cloning and functional expression of a
complementary DNA encoding
a mammalian nucleoside
transport protein. J. Biol. Chem. 1994, 269, 17757-17760.
(21) Ritzel, M. W.; Yao, S. Y.; Huang, M. Y.; Elliott, J. F.; Cass, C.
E.; Yound, J. D. Molecular cloning and functional expression of
cDNAs encoding
a
human Na+-nucleoside cotransporter
(hCNT1). Am. J. Phyisiol. 1997, 272, C707-C714.
(22) Che, M.; Ortiz, J. F.; Arias, I. M. Primary structure and func-
tional expression of a cDNA encoding the bile canalicular, pu-
rine-specific Na+-nucleoside cotransporter. J. Biol. Chem. 1995,
270, 13596-13599.
(23) Wang, J.; Su, S.-F.; Dresser, M. J.; Schaner, M. E.; Washing-
ton, C. B.; Giacomini, K. M. Na+-dependent purine nucleoside
(30) In case of compound 34, an additional protection-
deprotection step was needed to obtain the compound in pure
form.
(31) Figure of the most stable anti and syn conformers were pro-
vided in Supporting Information.
6
ACS Paragon Plus Environment